论文部分内容阅读
目的探讨美多芭用药干预对帕金森病疗效的影响。方法将社区临床诊断为帕金森病的48例患者随机分为对照组和实验组各24例,对照组采用常规的用药方法。实验组采用小量多次的用药方法,6个月后进行疗效评估。结果两组治疗6个月,实验组显效91.7%,对照组显效58.3%,两组显效率比较,p<0.05,差异有统计学意义。结论对美多芭用药干预,能明显减轻或缓解帕金森病患者的症状,提高治疗效果。
Objective To investigate the effect of Meddopa on the efficacy of Parkinson’s disease. Methods 48 patients with clinically diagnosed Parkinson’s disease in community were randomly divided into control group and experimental group, 24 cases in each group. The control group was given routine medication. The experimental group used a small amount of repeated medication, 6 months after the efficacy evaluation. Results The two groups of treatment for 6 months, the experimental group markedly 91.7%, 58.3% in the control group markedly effective rate was significant difference between the two groups, p <0.05, the difference was statistically significant. Conclusion Meddopa medication intervention can significantly reduce or alleviate the symptoms of Parkinson’s disease patients and improve the treatment effect.